Chief Medical Officer, Global Oncology Business Unit

By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda’s Privacy Notice and Terms of Use. I further attest that all information I submit in my employment application is true to the best of my knowledge.

Job Description

The Chief Medical Officer for the Oncology Business Unit (OBU) is a highly visible role within Takeda and will report directly to President of Global Oncology Business Unit (OBU).  This role will be an integral leader within the OBU responsible for driving the medical strategy and organizational culture as part of the OBU’s senior leadership team.

KEY RESPONSIBILITIES

The Chief Medical Officer, Global Oncology Business Unit will have the opportunity to shape the medical global product strategy for an exciting portfolio and pipeline and lead the further development of the global oncology medical team. This is a highly visible role, with regular interactions at the most senior levels of the organization, including the Takeda Executive Team. As a senior leadership role, it will require insightful balance of strategic planning for developing products for the future while fully promoting the in-line portfolio.

• Lead the Takeda Global Oncology Medical Affairs (GMAO) strategy.

• Implement and execute all aspects of GMAO plans and tactics.

• Establish and maintain strong relationships with Key Opinion Leaders (KOLs), payors and patients’ representatives in the global Oncology arena.

• Responsible for providing medical and scientific affairs leadership on a global basis for the countries of the Oncology Business Unit, specifically the United States, Japan, Germany, France, United Kingdom, Ireland, Italy, Spain and Canada. 

• Provide alignment and guidance on medical affairs Oncology strategies and plans in other countries.

• Ensure technical leadership and oversight for all Medical Office aspects of OBU programs.

• Provide strategic consultation and guidance on all decisions that have significant clinical components and implications for the oncology portfolio

• Partner with the R&D organization in setting the development strategy and driving the execution of the Oncology pipeline.

• Participate in key strategic initiatives for the OBU including business development assessment.

• Attract, develop and retain a best-in-class global medical affairs organization, role modeling and championing Takeda values.

PREFERRED QUALIFICATIONS:

• M.D with experience in Hematology, Oncology and Solid Tumors. Broader therapeutic experience in Rare Disease or Immunology would also be considered. Other advanced degrees (MBA, MPH) are desired.

• Substantive pharmaceutical industry experience including medical affairs and clinical development. Prior academic research and/or healthcare management experience is a plus.

• Demonstrates successful collaborative leadership including proven management experience in a complex industry setting; creates the environment that inspires and enables people to move the organization forward.

• Proven success setting medical and business strategy and in effective implementation.

• Proven track record in biopharmaceutical leadership, with the presence and intellectual acumen to influence and impact key decision makers, and with exceptional medical and strategic capabilities.

• Successful track record cultivating a high-performance organization; effective as a mentor and coach; able to identify, attract, develop, motivate and retain key talent.

• Drive results by focusing on the few priorities that matter most to deliver superior results.

• Well-developed skills in managing, training, developing & coaching high performing teams.

• Deep understanding of the pharmaceutical value chain, in